O'Brien Greene & Co. Inc Medpace Holdings, Inc. Transaction History
O'Brien Greene & Co. Inc
- $289 Million
- Q2 2025
A detailed history of O'Brien Greene & Co. Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 12,772 shares of MEDP stock, worth $5.55 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
12,772
Previous 12,375
3.21%
Holding current value
$5.55 Million
Previous $3.77 Million
6.31%
% of portfolio
1.39%
Previous 1.33%
Shares
3 transactions
Others Institutions Holding MEDP
# of Institutions
632Shares Held
26.3MCall Options Held
28.4KPut Options Held
80.8K-
Black Rock Inc. New York, NY2.58MShares$1.12 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$1.1 Billion0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.19MShares$515 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT829KShares$360 Million1.43% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$355 Million1.35% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $13.5B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...